Relief Therap 
Welcome,         Profile    Billing    Logout  
 3 Products   36 Diseases   3 Products   4 Trials   668 News 


«123456
  • ||||||||||  aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
    RLF-100 (Twitter) -  Aug 23, 2020   
  • ||||||||||  aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
    I hope it's not aviptadil. (Twitter) -  Aug 23, 2020   
  • ||||||||||  aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
    #RLF-100 (Twitter) -  Aug 8, 2020   
  • ||||||||||  Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NRx Pharma
    Enrollment change:  AVINALI: Inhaled ZYESAMI (clinicaltrials.gov) -  Jun 28, 2020   
    P2/3,  N=288, Not yet recruiting, 
    Not yet recruiting --> Recruiting N=144 --> 288
  • ||||||||||  aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
    [VIRTUAL] The effects of laser pulse duration on energy delivery and stone damage during laser lithotripsy (WEWCC: 146C) -  May 17, 2020 - Abstract #AUA2020AUA_2425;    
    This important observation demonstrates that fiber-stone distance is a critical parameter in treatment efficiency regardless of PD. Significantly, this is the first experimental validation of improved energy delivery to the stone with longer PDs with more pulse energy delivered following the formation of a vapor bubble.
  • ||||||||||  Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NRx Pharma
    New P2/3 trial:  AVINALI: Inhaled ZYESAMI (clinicaltrials.gov) -  Apr 23, 2020   
    P2/3,  N=144, Not yet recruiting, 
  • ||||||||||  Zyesami IV (aviptadil intravenous) / Relief Therap, NRx Pharma
    Enrollment change:  COVID-AIV: Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure (clinicaltrials.gov) -  Apr 13, 2020   
    P2,  N=120, Not yet recruiting, 
    Significantly, this is the first experimental validation of improved energy delivery to the stone with longer PDs with more pulse energy delivered following the formation of a vapor bubble. N=20 --> 120
  • ||||||||||  Journal:  Reflexions on 50 Years of Sexual Medicine in Urology Focusing on Male Sexual Dysfunctions (Pubmed Central) -  Feb 21, 2020   
    Regarding premature ejaculation (PE) meanwhile with oral dapoxetine and topical lidocaine/prilocaine spray two effective treatment options are officially available which may be combined in men with severe PE and with PDE-5 inhibitors in men with PE and ED. Hormonal disorders such as hypogonadism, hyperprolactinemia and thyroid disorders may be linked to male sexual disorders and successfully treated with T-substitution, prolactin inhibitors or thyroid specific medications.Whereas vascular surgery for ED such as deep dorsal vein ligation/resection or arterial revascularization procedures dominated the 80ies and 90ies last century they have been considered outdated and are replaced in severe ED of organic etiology by the modern new three piece inflatable penile implants whose high technical standard meanwhile provide 10 years survival rates of about 70 %.
  • ||||||||||  aviptadil (DK-1000) / Therametrics, United Therapeutics, Seren Clinical, Muse (alprostadil) / Mylan
    Clinical, Journal:  Erectile dysfunction: a global review of intracavernosal injectables. (Pubmed Central) -  Dec 20, 2019   
    ICIs are associated with good clinical efficacy rates, high discontinuation rates and a moderate side-effect profile. They represent an important tool in the urological armamentarium for treating ED in patients that cannot tolerate or are refractory to oral therapies.